@article{JTD19855,
author = {Yusuke Taniyama and Tadashi Sakurai and Takahiro Heishi and Hiroshi Okamoto and Chiaki Sato and Shota Maruyama and Yu Onodera and Hirotaka Ishida and Michiaki Unno and Takashi Kamei},
title = {Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Background: Clinical outcomes appear to differ between patients with residual or recurrent esophageal cancer after definitive chemoradiotherapy. We aimed to identify the patients most likely to benefit from this high-risk surgery, divided by the patients whose cancer was residual and recurrent groups, respectively.
Methods: We retrospectively examined 100 cases of patients who failed to respond to definitive chemoradiotherapy for thoracic esophageal squamous cell carcinoma and subsequently underwent salvage transthoracic esophagectomy.
Results: In-hospital morbidity was similar in both groups. T status prior to administration of chemoradiotherapy correlated with survival in the group with residual cancer (P=0.010), but this relationship was not significant in the group with recurrent cancer (P=0.635). On the other hand, pathological T status showed a significant correlation with survival in both the residual (P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/19855}
}